Sign In
Buy BLKB
Blackbaud Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $1.08 |
| EPS actual | $1.14 |
| EPS Surprise | 5.56% |
| Revenue estimate | 279.806M |
| Revenue actual | 281.14M |
| Revenue Surprise | 0.477% |
| Release date | Feb 10, 2026 |
| EPS estimate | $1.15 |
| EPS actual | $1.19 |
| EPS Surprise | 3.48% |
| Revenue estimate | 292.162M |
| Revenue actual | 295.256M |
| Revenue Surprise | 1.06% |
| Release date | Oct 29, 2025 |
| EPS estimate | $1.07 |
| EPS actual | $1.10 |
| EPS Surprise | 2.80% |
| Revenue estimate | 292.711M |
| Revenue actual | 281.143M |
| Revenue Surprise | -3.95% |
| Release date | Jul 30, 2025 |
| EPS estimate | - |
| EPS actual | $0.538 |
| Revenue estimate | - |
| Revenue actual | 281.382M |
Last 4 Quarters for Blackbaud
Below you can see how BLKB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $71.61 |
| EPS estimate | - |
| EPS actual | $0.538 |
| Date | Price |
|---|---|
| Jul 24, 2025 | $65.25 |
| Jul 25, 2025 | $65.40 |
| Jul 28, 2025 | $64.06 |
| Jul 29, 2025 | $64.50 |
| Jul 30, 2025 | $71.61 |
| Jul 31, 2025 | $67.42 |
| Aug 01, 2025 | $65.28 |
| Aug 04, 2025 | $64.78 |
| Aug 05, 2025 | $63.12 |
| 4 days before | 9.75% |
| 4 days after | -11.86% |
| On release day | -5.85% |
| Change in period | -3.26% |
| Release date | Oct 29, 2025 |
| Price on release | $67.95 |
| EPS estimate | $1.07 |
| EPS actual | $1.10 |
| EPS surprise | 2.80% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $64.71 |
| Oct 24, 2025 | $65.18 |
| Oct 27, 2025 | $64.46 |
| Oct 28, 2025 | $64.15 |
| Oct 29, 2025 | $67.95 |
| Oct 30, 2025 | $65.92 |
| Oct 31, 2025 | $64.04 |
| Nov 03, 2025 | $63.88 |
| Nov 04, 2025 | $62.06 |
| 4 days before | 5.01% |
| 4 days after | -8.67% |
| On release day | -2.99% |
| Change in period | -4.10% |
| Release date | Feb 10, 2026 |
| Price on release | $47.68 |
| EPS estimate | $1.15 |
| EPS actual | $1.19 |
| EPS surprise | 3.48% |
| Date | Price |
|---|---|
| Feb 04, 2026 | $47.85 |
| Feb 05, 2026 | $46.29 |
| Feb 06, 2026 | $47.48 |
| Feb 09, 2026 | $48.25 |
| Feb 10, 2026 | $47.68 |
| Feb 11, 2026 | $50.37 |
| Feb 12, 2026 | $47.71 |
| Feb 13, 2026 | $49.08 |
| Feb 17, 2026 | $47.34 |
| 4 days before | -0.355% |
| 4 days after | -0.713% |
| On release day | 5.64% |
| Change in period | -1.07% |
| Release date | Apr 29, 2026 |
| Price on release | $39.04 |
| EPS estimate | $1.08 |
| EPS actual | $1.14 |
| EPS surprise | 5.56% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $36.19 |
| Apr 24, 2026 | $37.49 |
| Apr 27, 2026 | $37.19 |
| Apr 28, 2026 | $37.51 |
| Apr 29, 2026 | $39.04 |
| Apr 30, 2026 | $37.17 |
| May 01, 2026 | $37.54 |
| May 04, 2026 | $37.59 |
| May 05, 2026 | $36.75 |
| 4 days before | 7.88% |
| 4 days after | -5.87% |
| On release day | -4.79% |
| Change in period | 1.55% |
Blackbaud Earnings Call Transcript Summary of Q1 2026
Blackbaud reported a solid start to FY2026 with Q1 organic revenue up 4.2% to $281M, adjusted EBITDA of $99M (+$7M YoY) and non-GAAP EPS of $1.14 (up 20% YoY). Free cash flow improved materially to $37M for the quarter. Management emphasized aggressive investment in AI (generative and agentic capabilities) both to accelerate product innovation and to improve internal productivity. They launched their first agentic product, the Fundraising Development Agent (part of an "Agents For Good" product category), which is commercially available and targeted for cross-sell to thousands of existing customers; pricing is expected to be in the "tens of thousands" per year. Blackbaud highlighted a strong data-driven competitive moat (proprietary philanthropic data, integrations and governed AI), continued new-logo wins (including large enterprise deals), and improving gross margins tied to legacy infrastructure rationalization. The company reaffirmed full-year 2026 guidance and reiterated multi-year financial aspirations for 2026–2030: organic revenue growth of 4–6% annually, adjusted EBITDA growth of 6–8% and a goal of 13%+ non-GAAP EPS CAGR (driven by both growth and aggressive share repurchases). Management expects cash flow generation to be heavily back-end weighted (Q4 concentration) and plans to deploy 50%+ of cumulative free cash flow from 2026–2030 to buybacks while retaining flexibility for debt paydown or tuck-in M&A.
